dromlakhani Triglyceride monitoring before and after bile acid sequestrant initiation
STEP 1 — Gather Information
Collect current fasting triglyceride level and assess clinical indication for bile acid sequestrant (e.g., for hypertriglyceridemia or adjunct glycemic control in diabetes).
STEP 2 — Rule In / Rule Out
Rule in if triglyceride level is between 150 mg/dL and 499 mg/dL; rule out if triglyceride level is <150 mg/dL or ≥500 mg/dL.
STEP 3 — Classify or Stratify
Classify as appropriate for bile acid sequestrant initiation with planned triglyceride monitoring if no contraindications (triglyceride level <500 mg/dL, already confirmed in step 2).
STEP 4 — Decide
Initiate bile acid sequestrant and schedule triglyceride measurement before initiation and 4-6 weeks after initiation to assess response and safety.
Clinical Guardrails / Mimics / Pitfalls
Do not initiate bile acid sequestrant if triglyceride level is ≥500 mg/dL due to risk of exacerbating hypertriglyceridemia and pancreatitis. Monitor for triglyceride elevation after initiation; if triglyceride rises to ≥500 mg/dL, discontinue and evaluate for alternative therapy.
Concrete Clinical Example
A 58-year-old patient with type 2 diabetes and fasting triglyceride of 280 mg/dL is prescribed colesevelam for glycemic adjunct. Pre-treatment triglyceride is 280 mg/dL. At 6-week follow-up, triglyceride is 310 mg/dL (increased but <500 mg/dL); therapy continues with lipid monitoring every 3 months.
Source: Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, doi:10.1210/clinem/dgaa674
TODO: consider adding scripts/calc.py for the endo-tg-check-bile-acid-sequestrant calculator